Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases
Frontiers in Microbiology · 02.03.2026 · 17
DOI: 10.3389/fmicb.2026.1812182 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Microbiology, online erschienen am 02.03.2026. Verfasst von Samira Tarashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.
- Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, India.
- Department of Microbiology and Immunology, University of Nevada, Reno, NV, United States.
- Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Tarashi, S., Baranwal, M., Khaiboullina, S., & Marjani, M. (2026). Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1812182
Vancouver
Tarashi S, Baranwal M, Khaiboullina S, Marjani M. Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1812182
BibTeX
@article{Tarashi2026,
author = {Tarashi, Samira and Baranwal, Manoj and Khaiboullina, Svetlana and Marjani, Majid},
title = {Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1812182}
}
EUVIMED